Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
156. Safety of Remibrutinib across Immune-mediated Diseases Supports Development in Multiple Sclerosis
2024
0 citations
Journal Article
Field-Weighted Citation Impact:
0.00
156. Safety of Remibrutinib across Immune-mediated Diseases Supports Development in Multiple Sclerosis | Researchclopedia
Jin Nakahara
·
Keio University
Robert Bermel
·
Cleveland Clinic
Thomas Dörner
·
Charité - Universitätsmedizin Berlin
Brett Loop
·
Novartis (United States)
Virginia DeLasHeras
·
Novartis (Switzerland)
Roman Willi
·
Novartis (Switzerland)
Sibylle Haemmerle
·
Novartis (Switzerland)
Artem Zharkov
·
Novartis (Switzerland)
Nathalie Barbier
·
Novartis (Switzerland)
Amin Azmon
·
Novartis (Switzerland)
Richard W. Siegel
·
Novartis (Switzerland)
Bruno Cenni
·
Novartis (Switzerland)
Imad Y. Haddad
·
Novartis (Australia)
Heinz Wiendl
·
University of Münster
Marcus Maurer
·
Charité - Universitätsmedizin Berlin
A.M. Giménez-Arnau
·
Pompeu Fabra University
Tanuja Chitnis
·
Brigham and Women's Hospital